Telehealth puts your lab results in a portal, often with minimal interpretation. Here's how to read the three panels that matter most on GLP-1 therapy — what each number is, what direction it should move, and which changes deserve a message to your provider.
Key Takeaways
- A1C reflects ~3 months of average glucose; expect meaningful improvement by the first on-treatment check if it started elevated.
- Triglycerides typically fall and HDL often rises with weight loss; LDL response is more variable.
- Mildly elevated liver enzymes at baseline frequently improve on therapy — falling ALT is often your fatty liver getting better.
- Trends across draws matter more than any single value; keep copies of everything, especially if you switch providers.
A1C: The Three-Month Average
Hemoglobin A1C estimates average blood glucose over the life of your red cells (~3 months). Below 5.7% is normal; 5.7–6.4% is the prediabetes band; 6.5%+ meets diabetes criteria. GLP-1s were diabetes drugs first — glucose control is their home turf — so an elevated baseline A1C should improve visibly by your first follow-up panel. A patient starting at 6.1% who lands at 5.6% has, by the numbers, exited the prediabetes range. That's a headline result worth understanding when you see it.
The Lipid Panel
- Triglycerides respond fastest to weight loss and carbohydrate reduction — this is often the most dramatic improvement on the panel. (Note: a non-fasting draw inflates triglycerides; check which yours was before worrying.)
- HDL tends to drift upward with fat loss and activity. Slow mover; judge it over 6–12 months.
- LDL is the variable one — it often improves modestly but is heavily genetic. If everything else improves and LDL doesn't, that's a statin conversation, not a weight-loss failure.
Liver Enzymes: ALT and AST
Mild ALT elevation in a patient with obesity usually reflects fatty liver (MASLD). Because GLP-1 weight loss is genuinely good for fatty liver, watching ALT drift from, say, 55 down into the normal range across two draws is watching your liver improve in real time. A rising trend, or values several times the upper limit, warrants provider attention promptly.
The Rest of the Metabolic Panel
Fasting glucose corroborates the A1C. Creatinine/eGFR confirm kidney function — worth glancing at during any period of poor fluid intake from appetite suppression. Sodium and potassium rarely move, but severe vomiting episodes can shift them, which is one reason to report severe GI symptoms rather than white-knuckling them.
Practical Portal Habits
Download PDFs of every panel — portals vanish when you switch providers. Put your draws on a schedule (baseline, ~3–6 months, then every 6–12) and compare trend lines, not single values. And choose a provider whose clinicians actually discuss results with you:
Embody
Injectable semaglutide — $149 first month
Physician-supervised injectable semaglutide program with straightforward flat monthly pricing after the intro month.
Compounded medications are not FDA-approved.
Visit Embody Paid linkSesame Care
Brand-name only — Rybelsus and oral Wegovy from $149–$299/mo
Marketplace access to brand-name FDA-approved oral GLP-1s only — no compounded products.
Visit Sesame Care Paid linkYour labs are the objective story of your treatment — better evidence than the scale, honestly. Learn to read them and you'll never again wonder whether the therapy is "working."
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.